|
SILVER SPRING, Md., March 6, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing's disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease.... |
